Pharma Pathway

MARCH 13, 2023

Our bioequivalence centre was established in 2005 and is responsible for conducting studies for filing product registrations with various regulatory authorities. Ranked amongst the top 10 pharma companies with a strength of 20000 employees, operating in 140+ countries.

Pharmaceutical 80

Pharmaceutical Pharma 80

Pharma Pathway

JANUARY 1, 2023

Our bioequivalence centre was established in 2005 and is responsible for conducting studies for filing product registrations with various regulatory authorities. Macleods Pharmaceuticals, Indian’s fastest growing company was established in 1986.

Pharmaceutical 85

Pharmaceutical Pharma 85

Pharma Pathway

FEBRUARY 11, 2023

Our bioequivalence centre was established in 2005 and is responsible for conducting studies for filing product registrations with various regulatory authorities. Ranked amongst the top 10 pharma companies with a strength of 20000 employees, operating in 140+ countries.

Pharmaceutical 84

Pharmaceutical Pharma Management 84

Pharma Pathway

MARCH 2, 2023

Our bioequivalence centre was established in 2005 and is responsible for conducting studies for filing product registrations with various regulatory authorities. Ranked amongst the top 10 pharma companies with a strength of 20000 employees, operating in 140+ countries.

Pharmaceutical 90

Pharmaceutical Electronics Pharma 90

Pharma Pathway

MARCH 4, 2023

Our bioequivalence centre was established in 2005 and is responsible for conducting studies for filing product registrations with various regulatory authorities. Ranked amongst the top 10 pharma companies with a strength of 20000 employees, operating in 140+ countries.

Pharmaceutical 80

Pharmaceutical Electronics Pharma 80

Pharma Pathway

MARCH 2, 2023

Our bioequivalence centre was established in 2005 and is responsible for conducting studies for filing product registrations with various regulatory authorities. Ranked amongst the top 10 pharma companies with a strength of 20000 employees, operating in 140+ countries.

Pharmaceutical 81

Pharmaceutical Electronics Pharma Management 81

World of DTC Marketing

JANUARY 3, 2022

spent $190 billion on obesity-related health care expenses in 2005-double previous forecast. (1) Compared with those with average weight, adults with obesity in the United States experienced higher annual medical care costs by $2,505 or 100%, with prices increasing significantly with the class of obesity. By one estimate, the U.S.

Healthcare 234

Healthcare Healthcare Insurance Prescription 234

Pharma Pathway

FEBRUARY 1, 2023

Our bioequivalence centre was established in 2005 and is responsible for conducting studies for filing product registrations with various regulatory authorities. Ranked amongst the top 10 pharma companies with a strength of 20000 employees, operating in 140+ countries.

Pharmaceutical 52

Pharmaceutical Pharma 52

Pharma Pathway

JANUARY 5, 2023

Our bioequivalence centre was established in 2005 and is responsible for conducting studies for filing product registrations with various regulatory authorities. Macleods Pharmaceuticals, Indian’s fastest growing company was established in 1986.

Pharmaceutical 52

Pharmaceutical Pharma 52

Medical Device Success

OCTOBER 10, 2021

Over 30 years ago, Paula began her career in the medical device industry and in 2005, founded Legacy MedSearch and turned it into one of the most highly sought after MedTech search firms in the USA. Reading time: 2 – 4 minutes. More change in the last 18 months than in the past 30 years.”.

Recruitment 130

Recruitment Medical Sales Marketing 130

PM360

MARCH 22, 2024

A study from The National Cancer Institute revealed that the number of women who were unaware they should get these screenings went up from 45% in 2005 to 55% in 2019. The number of women who said they did not get a recommendation from a healthcare professional to get these screenings also doubled, from 6% in 2005 to 12% in 2019.

Food and Drug Administration 52

Food and Drug Administration FDA Healthcare Healthcare 52

PM360

MARCH 24, 2023

Within the past 40 years, 202 new awareness days were introduced to Congress—71% of these were introduced after 2005. We’re seeing more and more awareness days, weeks, and months emerge in large part due to the rise of social media. This is right around the time social media was really taking off.

Media 92

Media Education Pharma Networking 92

pharmaphorum

OCTOBER 7, 2022

Starting with the primary care era of 1997-2005, when key launches were primary care blockbusters, such as Losec, Diovan, and Lipitor, IQVIA took five key therapy classes from that era that consistently appeared in the top 10 therapy area by sales for the time period of the era.

Competition 73

Competition Marketing Medicine Pharmaceutical 73

European Pharmaceutical Review

OCTOBER 2, 2023

Through [their] discoveries, Karikó and Weissman opened up opportunity for the pharmaceutical industry to advance mRNA technology” These data were published in 2005, fifteen years before the COVID-19 pandemic, of which mRNA vaccines were instrumental to controlling.

Medicine 109

Medicine Pharmaceutical Pharma Leads 109

Copyright Clearance Center

SEPTEMBER 1, 2022

Foster has been a member of CCC’s Board since 2005, previously holding the position of Audit Committee Chair, and currently serves on the Executive Committee. Foster succeeds Jack Hoeft, who served as Chairman for over 20 years.

Distribution 52

Distribution Specialization Leads Management 52

Pharma Marketing Network

MAY 3, 2023

As such, it is important for the industry to carefully consider the effects of these advertisements and to take steps to ensure that they are promoting the right messages in the right ways. References: 1. Powerful Medicines: The Benefits, Risks, and Costs of Prescription Drugs. Knopf Doubleday Publishing Group. Goozner, M. Steinman, M.

Pharmaceutical 52

Pharmaceutical Healthcare Provider Prescription Healthcare 52

Clarivate

NOVEMBER 1, 2021

These include Handbook of Quantitative Science and Technology Research (2004), Citation Analysis in Research Evaluation (2005), Applied Evaluative Informetrics (2017), Handbook of Science and Technology Indicators (edited with W. His books became the cornerstone of bibliometrics education. Glänzel, U. Schmoch and M. Thelwall) in 2018.

Education 105

Education Government 105

Clarivate

MAY 8, 2023

Artios Pharma CEO Niall Martin recalled the sale of KuDOS Pharmaceuticals to AstraZeneca for $210m in late 2005 and advised that there will always be a question mark about the right time to sell when there is pressure in the system to sell assets, which is mirrored in today’s biotech environment.

Biopharma 52

Biopharma Sales Networking Pharma 52

World of DTC Marketing

JUNE 5, 2021

From 2005 to 2014, most cancers associated with overweight and obesity increased in the United States, while cancers associated with other factors decreased. Breast (in women who have gone through menopause). Colon and rectum. Gallbladder. Upper stomach. Meningioma (a type of brain cancer). Multiple myeloma.

Government 193

Government Medicine Food Management 193

PM360

AUGUST 9, 2022

According to a 2021 study by Statista, 40% of prescriptions written in 2005 were for brand-name medications. By 2020, that percentage plummeted to just 8%. 1 How is this possible, given that more than 20,000 prescription drugs are currently in circulation in the U.S.

Prescription 52

Prescription Doctors Specialization Physicians 52

pharmaphorum

NOVEMBER 7, 2022

Since Mitch helped to found Aerie as a Duke University spinout in 2005, Aerie has filed 5 INDs and 2 NDAs, with its first FDA approval coming in 2017 and Najam (Naj) Sharif, PhD, DSc (Southampton University, UK) has >34-years’ pharmaceutical drug discovery research/development experience covering neuroscience and ophthalmology.

Pharmaceutical 52

Pharmaceutical Media Engineering Management 52

Pharmaceutical Technology

FEBRUARY 14, 2023

In 2005, the FDA approved Bristol-Myers Squibb's Abraxane, a PX albumin-bound nanoparticle formulation with 130nm particles, for treating metastatic breast cancer. Bristol-Myers Squibb is the leading patent filer in nanoparticles for drug delivery.

Leads 59

Leads Pharmaceutical Transportation FDA 59

Medico Reach

AUGUST 1, 2022

The whole Sprout healthcare technology team broke out into NLV in 2005. As a spin-off of the Sprout Group, NLVP has been participating in biopharma since 2005. New Leaf Venture Partners (NLVP) invested in biopharmaceuticals during their growth and venture phases.

Biopharma 52

Biopharma Healthcare Healthcare Specialization 52

pharmaphorum

NOVEMBER 25, 2022

David James has a long history within global product forecasting and consulting and co-launched J+D in 2005. About the author. He became CEO in 2011, as the company moved from purely consulting to developing forecast models, and has continued to evolve the business, using innovative technology to drive efficiencies for clients’ processes.

Marketing 116

Marketing Consulting Patients Sales 116

Legacy MEDSearch

AUGUST 31, 2023

More information: Expert insights on how to navigate the new mandatory A2P 10DLC industry requirements FCC Fact Sheet on Text Messaging Text Message Revenue Growth Since 2005 Text Carriers Announce New Requirements Our team is working hard to deliver the best experience to our candidates and hiring managers, and we respect anyone’s option (..)

Recruitment 52

Recruitment Networking Management Medical 52

pharmaphorum

OCTOBER 6, 2022

He served as Director of the Lowe Family Genomics Core at the Johns Hopkins University from 2005-15. He trained in Molecular Biology and earned a doctorate in Genetics from George Washington University, followed by a postdoctoral fellowship at the National Institute of Aging in the Microarray Core.

Side effects 98

Side effects Doctors Leads Training 98

pharmaphorum

JANUARY 27, 2023

He previously held regional leadership roles at Sandoz between 2005 and 2010. Saynor has a wealth of experience in the pharmaceutical industry, including at both innovation-driven companies and generics makers.

Medicine 88

Medicine Government Marketing Transportation 88

European Pharmaceutical Review

MARCH 1, 2023

PharmTech 2005 Apr 1. J Food Science 2005; 70(7): e437-e442 [[link] 5. Measurement of density variations in tablets using X-ray computed tomography. Int J Pharm 2004; 271(1-2): 215–24 [[link] 15129988] 2. Hancock BC, Mullarney MP. X-ray Microtomography of Solid Dosage Forms. Sovány T, Kása P, Vakli K, Pintye-Hódi K. X-Ray Spectrom.

Distribution 89

Distribution Electronics Pharmaceutical Food 89

European Pharmaceutical Review

OCTOBER 19, 2022

FDA highlighted that over three quarters of new patents in the Orange Book between 2005 and 2015 were assigned to existing drugs. 10 There is a fear that such practices discourage innovative approaches, impacting on patient welfare. Finally, product hopping is another tactic for hindering generic entry into the market.

Food and Drug Administration 80

Food and Drug Administration Pharmaceutical products Pharmacology FDA 80

Clarivate

NOVEMBER 17, 2021

After a successful time there, where I established an international reputation and worked with some outstanding colleagues, I moved back to the United States in 2005 and then onto my current position at the University of Sydney in 2012.

Leads 98

Leads Government Patients 98

European Pharmaceutical Review

JULY 13, 2023

2005 Dec;146(7):913-5. Expert Review of Clinical Pharmacology. 2023 Mar 4;16(3):257-66. Mechoulam R. Plant cannabinoids: a neglected pharmacological treasure trove. British journal of pharmacology. Hay M, Thomas DW, Craighead JL, et al. Clinical development success rates for investigational drugs. Nature biotechnology. 2014 Jan;32(1):40-51.

Medical 90

Medical Food and Drug Administration Pharmacology Medicine 90

Clarivate

NOVEMBER 14, 2023

The first GLP-1 RA used for diabetes (short-acting exenatide) became available in 2005 (US)/2006 (Europe) and required twice-daily injection. Since then, two GLP‑1 RAs requiring only once-daily injection have become available, followed by three which require only once-weekly injection (Figure 1). [7]

Food and Drug Administration 52

Food and Drug Administration Medicine Patients Food 52

Pharmaceutical Technology

OCTOBER 5, 2022

In 2005, Biogen withdrew Tysabri from the market following a clinical trial that resulted in two participants contracting progressive multifocal leukoencephalopathy (PML). It is also important to ask whether doctors are being paid fair market value and if they are providing the services for which they’re being compensated, he adds.

Government 59

Government Specialization Physicians Education 59

European Pharmaceutical Review

OCTOBER 30, 2023

Graham originally qualified as a solicitor in London in 2005, before moving to co-found technology and software company MET, which was subsequently sold to a group of private investors in 2008.

Distribution 101

Distribution Manufacturing Pharmaceutical Government 101

pharmaphorum

OCTOBER 31, 2022

David James has a long history within global product forecasting and consulting and co-launched J+D Forecasting in 2005. By defining the remit, you can begin to identify whether features within the model are necessary additions or ‘nice-to-haves’ to keep it simple. About the author.

Pharmaceutical 52

Pharmaceutical Marketing Consulting Leads 52

European Pharmaceutical Review

APRIL 21, 2023

Giving environmental risk assessments teeth Since 2005, the authorisation of a human pharmaceutical product requires an environmental risk assessment (ERA). In addition, the number of active substances detected in the environment has been increasing with unknown consequences for ecosystems and the accumulation of substances in food chains.

Pharma 87

Pharma Food and Drug Administration Medicine Pharmaceutical 87

pharmaphorum

AUGUST 17, 2022

They are a stripped-down version with 29 indicators; the 2005 PICTF had 46. Indicators from the 2000s were captured in the Pharmaceutical Industry Competitiveness Task Force (PICTF) Indicators. The July 2022 LSCIs are the eighth version.

Competition 59

Competition Medicine Patients Government 59